Results
|
1521.
|
|
|
1522.
|
Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial. [electronic resource] by
- Nissen, Steven E
- Dent-Acosta, Ricardo E
- Rosenson, Robert S
- Stroes, Erik
- Sattar, Naveed
- Preiss, David
- Mancini, G B John
- Ballantyne, Christie M
- Catapano, Alberico
- Gouni-Berthold, Ioanna
- Stein, Evan A
- Xue, Allen
- Wasserman, Scott M
- Scott, Rob
- Thompson, Paul D
Producer: 20161219
In:
Clinical cardiology vol. 39
Availability: No items available.
|
|
1523.
|
Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial. [electronic resource] by
- Virani, Salim S
- Akeroyd, Julia M
- Nambi, Vijay
- Michos, Erin D
- Morris, Pamela B
- Nasir, Khurram
- Smith, Sidney C
- Stone, Neil J
- Petersen, Laura A
- Ballantyne, Christie M
Producer: 20191028
In:
Circulation vol. 139
Availability: No items available.
|
|
1524.
|
|
|
1525.
|
A small molecule inhibitor of PCSK9 that antagonizes LDL receptor binding via interaction with a cryptic PCSK9 binding groove. [electronic resource] by
- Evison, Benny J
- Palmer, James T
- Lambert, Gilles
- Treutlein, Herbert
- Zeng, Jun
- Nativel, Brice
- Chemello, Kévin
- Zhu, Qing
- Wang, Jie
- Teng, Yanfen
- Tang, Wei
- Xu, Yanfeng
- Rathi, Anuj Kumar
- Kumar, Sanjay
- Suchowerska, Alexandra K
- Parmar, Jasneet
- Dixon, Ian
- Kelly, Graham E
- Bonnar, James
Producer: 20210427
In:
Bioorganic & medicinal chemistry vol. 28
Availability: No items available.
|
|
1526.
|
|
|
1527.
|
|
|
1528.
|
A novel loss of function mutation of PCSK9 gene in white subjects with low-plasma low-density lipoprotein cholesterol. [electronic resource] by
- Fasano, Tommaso
- Cefalù, Angelo B
- Di Leo, Enza
- Noto, Davide
- Pollaccia, Daniela
- Bocchi, Letizia
- Valenti, Vincenza
- Bonardi, Renato
- Guardamagna, Ornella
- Averna, Maurizio
- Tarugi, Patrizia
Producer: 20070307
In:
Arteriosclerosis, thrombosis, and vascular biology vol. 27
Availability: No items available.
|
|
1529.
|
|
|
1530.
|
|
|
1531.
|
|
|
1532.
|
|
|
1533.
|
|
|
1534.
|
|
|
1535.
|
Thyroid stimulating hormone exhibits the impact on LDLR/LDL-c via up-regulating hepatic PCSK9 expression. [electronic resource] by
- Gong, Yingyun
- Ma, Yizhe
- Ye, Zhengqin
- Fu, Zhenzhen
- Yang, Panpan
- Gao, Beibei
- Guo, Wen
- Hu, Dandan
- Ye, Jingya
- Ma, Shuai
- Zhang, Fan
- Zhou, Li
- Xu, Xinyu
- Li, Zhong
- Yang, Tao
- Zhou, Hongwen
Producer: 20171019
In:
Metabolism: clinical and experimental vol. 76
Availability: No items available.
|
|
1536.
|
|
|
1537.
|
|
|
1538.
|
|
|
1539.
|
Triple-Targeting Delivery of CRISPR/Cas9 To Reduce the Risk of Cardiovascular Diseases. [electronic resource] by
- Zhang, Lingmin
- Wang, Le
- Xie, Yangzhouyun
- Wang, Peng
- Deng, Sai
- Qin, Aiping
- Zhang, Jiangjiang
- Yu, Xiyong
- Zheng, Wenfu
- Jiang, Xingyu
Producer: 20200923
In:
Angewandte Chemie (International ed. in English) vol. 58
Availability: No items available.
|
|
1540.
|
Meta-analysis of Randomized Controlled Trials Assessing the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies on Mortality and Cardiovascular Outcomes. [electronic resource] by
- AlTurki, Ahmed
- Marafi, Mariam
- Dawas, Ahmed
- Dube, Marie-Pierre
- Vieira, Lucy
- Sherman, Mark H
- Gregoire, Jean
- Thanassoulis, George
- Tardif, Jean-Claude
- Huynh, Thao
Producer: 20200401
In:
The American journal of cardiology vol. 124
Availability: No items available.
|